Impact of Severe Teratozoospermia on Assisted Reproductive Technology Outcomes: A Systematic Review
Keywords:
severe teratozoospermia; sperm morphology; assisted reproductive technology; intrauterine insemination; in vitro fertilization; intracytoplasmic sperm injection; fertilization rate; male infertility.Abstract
Introduction: The clinical relevance of severe teratozoospermia in assisted reproductive technology (ART) remains controversial. Although sperm morphology is widely used to assess male fertility, its predictive value for treatment outcomes is still debated.
Methods: A systematic review was conducted according to PRISMA 2020 guidelines. Studies evaluating ART outcomes in men with severe teratozoospermia (<4% normal forms according to strict morphology criteria) were identified through PubMed/MEDLINE, Scopus, and Web of Science. Human studies published between 1995 and May 2026 were screened. Outcomes included fertilization, embryo development, clinical pregnancy, implantation, and live birth.
Results: Eighteen evidence sources met the inclusion criteria. Severe teratozoospermia was generally associated with poorer outcomes following intrauterine insemination (IUI), with lower pregnancy rates compared with men presenting higher percentages of normal sperm forms. In conventional in vitro fertilization (IVF), results were heterogeneous, with some studies reporting reduced fertilization and embryo quality, whereas others found no significant effect on pregnancy outcomes. In contrast, intracytoplasmic sperm injection (ICSI) consistently achieved favorable fertilization, pregnancy, and live-birth rates, even in cases of extremely poor sperm morphology. Some evidence suggests that severe teratozoospermia may impair embryo development through underlying sperm DNA and chromatin abnormalities.
Conclusions: Severe teratozoospermia negatively affects IUI outcomes and may reduce fertilization potential in conventional IVF. ICSI effectively overcomes most morphology-related barriers and remains the most reliable ART option for severe male-factor infertility. Further prospective studies are needed to clarify the predictive value of sperm morphology in ART.

